We were pleased with the opportunity to co-promote XIFAXAN, ... We are confident that XIFAXAN should serve as a major contributor to Salix's ongoing success. ALTANA has made the strategic decision to realign its efforts in the respiratory therapeutic area. Therefore, in order to focus our efforts, ALTANA and Salix have agreed to end their co-promotion activities. George Cole